Results of the present study show that the levels of caspase-3 in the kidney tissue homogenate were significantly increased in the Fe-NTA + Zn-NPs group upon their comparison with the normal control and Fe-NTA groups, confirming the antitumor efficacy of Zn-NPs in renal cancer treatment. The gene discussed is CASP3; the disease is renal carcinoma.